يعرض 1 - 10 نتائج من 15 نتيجة بحث عن '"Vaccines, Conjugate/immunology"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Physiologie, physiopathologie et thérapeutique (ED 394), Sorbonne Université (SU), Neovacs S.A [Paris], Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Neuropathologie expérimentale / Experimental neuropathology, Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), E.C. is the recipient of a CIFRE Ph.D. fellowship. B.B. was supported partly by a stipend from the Pasteur—Paris University (PPU) International Ph.D. program, and a fellowship from the French 'Fondation pour la Recherche Médicale FRM'. N.G. acknowledges funding from the European Research Council (ERC-2018-STG, No. 802041) and the INSERM ATIP-Avenir program, B.H.K. acknowledges funding from the National Institutes of Health (NIH) HL093735 and an Award from the American Asthma Foundation. L.L.R. acknowledges support from the ATIP-Avenir program, and P.B. from the European Research Council (ERC)–Seventh Framework Program (ERC-2013-CoG 616050). This work was supported by a grant from the French National Research Agency ANR-18-CE18-0023 'AllergyVACS', NEOVACS, the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Institut Pasteur., ANR-18-CE18-0023,AllergyVACS,Développement d'un vaccin thérapeutique pour les maladies allergiques(2018), European Project: 802041, European Project: 616050,EC:FP7:ERC,ERC-2013-CoG,MYELOSHOCK(2014), Gestionnaire, Hal Sorbonne Université, APPEL À PROJETS GÉNÉRIQUE 2018 - Développement d'un vaccin thérapeutique pour les maladies allergiques - - AllergyVACS2018 - ANR-18-CE18-0023 - AAPG2018 - VALID, ERC-2018-STG - 802041 - INCOMING, Role of myeloid cells, their mediators and their antibody receptors in allergic shock (anaphylaxis) using humanized mouse models and clinical samples - MYELOSHOCK - - EC:FP7:ERC2014-09-01 - 2019-08-31 - 616050 - VALID, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Toulouse [Toulouse], Institut Pasteur [Paris]-Université de Paris (UP), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Nature Communications
    Nature Communications, 2021, 12 (1), pp.2574. ⟨10.1038/s41467-021-22834-5⟩
    Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
    Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.2574. ⟨10.1038/s41467-021-22834-5⟩

    وصف الملف: application/pdf

  3. 3

    المصدر: BMC Infectious Diseases
    Assing, K, Nielsen, C, Jakobsen, M, Andersen, C B, Skogstrand, K, Gaini, S, Preiss, B, Mortensen, S B, Skov, M N & Rasmussen, L D 2020, ' Potential anti-EBV effects associated with elevated interleukin-21 levels : a case report ', BMC Infectious Diseases, vol. 20, 878 . https://doi.org/10.1186/s12879-020-05609-z

    وصف الملف: application/pdf

  4. 4

    المساهمون: Manchester Royal Infirmary, University of Manchester [Manchester], Instituto de Salud Pública de Chile (ISP), University of the East – Ramon Magsaysay Memorial Medical Center [Philippines], Norwegian Institute of Public Health [Oslo] (NIPH), University of the West of England [Bristol] (UWE Bristol), Malvinas Children's Hospital [Buenos Aires], Université Laval [Québec] (ULaval), National Institute of Public Health = Instituto Nacional de Salud Pública [Cuernavaca, Mexique] (INSP), Meningitis Research Foundation [Bristol], Confederation of Meningitis Organisations [Bristol] (CoMO), National Institute of Infectious Diseases [Tokyo], Dhaka Shishu Hospital [Bangladesh], Scientific Research Institute of Children's Infections [Saint-Petersburg, Russia], Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], University of Cambridge [UK] (CAM), Institute of Health Carlos III, National Institute for Communicable Diseases [Johannesburg] (NICD), FCM Santa Casa de São Paulo School of Medical Sciences [São Paulo], The GMI is funded by an educational grant from Sanofi Pasteur, however, the group is not led in any way by the company. GMI members determine meeting agenda items and lead the discussions and outputs. Medical writing support was provided by Shelley Lindley, PhD, of PAREXEL, which was funded by Sanofi Pasteur. R Borrow and J Findlow perform contract research on behalf of Public Health England for Baxter Biosciences, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur, and Sanofi Pasteur MSD. DA Caugant has performed in the past contract research on behalf of the Norwegian Institute of Public Health for Novartis, Pfizer, and Sanofi Pasteur. H Christensen has received an honorarium from Sanofi Pasteur for running a GMI modeling workshop paid to her employer. Furthermore, H Christensen is supported by the National Institute for Health Research [PDF-2012-05-245] and is a member of the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol, UK. S Sidorenko has received grants from Pfizer, outside the submitted work. P De Wals has received research grants and reimbursements of travel expenses from vaccine manufacturers including GlaxoSmithKline, Novartis, Sanofi Pasteur, and Pfizer, as well as from governmental agencies including the Quebec Ministry of Health and Social Services, Health Canada, and the Public Health Agency of Canada. J Carlos has received research grant support from GlaxoSmithKline, Novartis, and Sanofi Pasteur, however, no conflict of interest relevant to this manuscript is reported. M-K Taha performs contract research on behalf of Institut Pasteur for GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. C Trotter received a consulting payment from GlaxoSmithKline in 2013 for critical review of a health economic model of meningococcal vaccines and an honorarium from Sanofi Pasteur in 2015 for running a GMI modeling workshop. JA Vázquez Moreno performed contract research on behalf of Institute of Health Carlos III for Baxter Biosciences, GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. A von Gottberg received research funding from Pfizer. MAP Sáfadi has received grants to support research projects from GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. This work is produced by the authors under the terms of the research training fellowships issued by the NIHR. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, NIHR, the Department of Health, or Public Health England. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed., Global Meningococcal Initiative, Institut Pasteur [Paris] (IP)

    المصدر: Expert Review of Vaccines
    Expert Review of Vaccines, Expert Reviews (formerly Future Drugs), 2017, 16 (4), pp.313-328. ⟨10.1080/14760584.2017.1258308⟩
    Borrow, R, Alarcon, P, Carlos, J, Caugant, D, Christensen, H, Debbag, R, De Wals, P, Echániz-Aviles, G, Findlow, J, Head, C, Holt, D, Kamiya, H, Saha, S, Sidorenko, S, Taha, M-K, Trotter, C, Vázquez Moreno, J & Von Gottberg, A 2016, ' The global meningococcal initiative : global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection ', Expert Review of Vaccines, vol. 16, no. 4, pp. 313-328 . https://doi.org/10.1080/14760584.2017.1258308
    Expert Review of Vaccines, 2017, 16 (4), pp.313-328. ⟨10.1080/14760584.2017.1258308⟩

    مصطلحات موضوعية: 0301 basic medicine, Epidemiology, MESH: Meningococcal Vaccines/immunology, MESH: Global Health, Neisseria meningitidis, medicine.disease_cause, Global Health, MESH: Immunization Programs, Disease Outbreaks, MESH: Neisseria meningitidis/immunology, MESH: Meningococcal Infections/prevention & control, MESH: Meningococcal Infections/epidemiology, 0302 clinical medicine, prevention, MESH: Meningococcal Vaccines/therapeutic use, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Drug Discovery, Global health, 030212 general & internal medicine, MESH: Incidence, Global Meningococcal Initiative, MESH: Vaccines, Conjugate/immunology, Incidence, MESH: Meningitis, Meningococcal/immunology, MESH: Disease Outbreaks/prevention & control, 3. Good health, Vaccination, outbreaks, surveillance, Molecular Medicine, African meningitis belt, serogroups, 030106 microbiology, Immunology, Meningococcal Vaccines, Meningococcal vaccine, MESH: Meningitis, Meningococcal/epidemiology, Meningitis, Meningococcal, Meningococcal disease, 03 medical and health sciences, Environmental health, MESH: Meningitis, Meningococcal/prevention & control, Epidemiology, Global Meningococcal Initiative, meningococcal disease, MenW, Neisseria meningitidis, outbreaks, prevention, serogroups, surveillance, vaccination, medicine, Humans, MESH: Vaccines, Conjugate/therapeutic use, MenW, Pharmacology, meningococcal disease, Vaccines, Conjugate, MESH: Humans, business.industry, Immunization Programs, Outbreak, medicine.disease, vaccination, Meningococcal Infections, Carriage, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Neisseria meningitidis/classification, business, MESH: Meningococcal Infections/immunology

    وصف الملف: application/pdf

  5. 5
  6. 6

    المساهمون: Repositório da Universidade de Lisboa

    المصدر: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
    Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
    instacron:RCAAP
    Repositório Científico de Acesso Aberto de Portugal
    Repositório Científico de Acesso Aberto de Portugal (RCAAP)

    وصف الملف: application/pdf

  7. 7
  8. 8
  9. 9
  10. 10
    مورد إلكتروني

    المصدر: Howitz , M F , Harboe , Z B , Ingels , H , Valentiner-Branth , P , Mølbak , K & Djurhuus , B D 2017 , ' A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000-2014 ' , Vaccine , vol. 35 , no. 43 , pp. 5858-5863 .

    URL: https://curis.ku.dk/portal/da/publications/a-nationwide-study-on-the-impact-of-pneumococcal-conjugate-vaccination-on-antibiotic-use-and-ventilation-tube-insertion-in-denmark-20002014(cb092376-9b97-473c-a48d-a6987ba8281c).html
    https://doi.org/10.1016/j.vaccine.2017.09.006